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were assigned a score. Scores relevant to each individual patient
were totaled and this equated to an acuity level. Validation and
reliability testing were performed and the tool piloted for 4 weeks
in 6 different units. All units were Haematology/SCT (adult and
pediatric) but may also have included Oncology. Analysis of the
results shows that 86% of the nurses using the tool believed that
the acuity of their patient was accurately reﬂected. Of those who
didn’t agree with the tool’s rating, all believed that the acuity level
should have been higher, particularly those patients whose condi-
tion was unstable and whose acuity rating was on the border line
between levels. Compliance in units that did not receive face-to-
face orientation was lower.
A major limitation of the study was an unrealistic timeframe
which impacted on validity and reliability testing and compliance.
More extensive trialing of a reﬁned tool is planned. The develop-
ment of this tool provides a sound tool on which to build, whilst
succinctly demonstrating the difﬁculties in accurately assessing the
acuity of SCT/Haematology patients.
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DEVELOPING THE CRITICAL THINKING SKILLS OF NOVICE NURSES IN
BLOOD AND MARROW TRANSPLANTATION
Mishaw, K. University of Texas, Houston, TX.
Today’s nursing shortage is evidenced by fewer nurses entering
the workforce, acute nursing shortages in certain geographic areas,
and a shortage of nurses prepared to meet specialty patient needs
in a changing health care environment. This is clearly evident in
the blood and marrow transplant unit at MDACC, which processes
approximately 500 transplants per year. It is a challenge to recruit
nurses with cancer experience, much less, with a background in this
specialty. Nurses new to the blood and marrow transplant arena are
challenged with complex information including hematology, im-
munology as well as acute and chronic complications of the trans-
plant treatment modality. This BMT unit reﬁned its current ori-
entation program to include evidence-based practice and
implemented strategies for critical thinking skills. Methods were
developed and implemented to train the nurse coaches to teach
critical thinking skills. Tools were developed for use by both the
coach and new nurse to promote critical thinking. Tools developed
include orientation pathways with transplant modules, communi-
cation tools, and coach manual with coaching cards. These tools
will be presented and outcomes impacting length of orientation,
retention, coach satisfaction, and new nurse satisfaction will be
detailed.
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SAFETY OF LEUKAPHERESIS IN DONORS AND PATIENTS WITH WBC
COUNTS GREATER THAN 60K
Drago, S.S. Duke University Medical Center, Durham, NC.
As new protocols are developed and treatment plans change, the
demand for higher numbers of donor stem cells for patients has
increased. This is especially true for non-myeloablative transplants
where a higher cell dose may be needed to assure engraftment.
There is a concern for safety in this donor population that elevated
white blood cell counts may lead to altered blood ﬂow kinetics,
cause shortness of breath, decreased cerebral blood ﬂow, and con-
tribute to cardiac ischemia.
In reviewing 3037 leukapheresis collections in Duke University
adult bone marrow stem cell transplant program over a 7-year
period, it was noted that pre-leukapheresis WBC counts were
greater than or equal to 60,000/microliter in 296 cases (9.75%). A
WBC count greater than or equal to 100,000 was noted in 7 cases
(0.23%).
In reviewing our apheresis records for patients with WBC
greater than 60,000/microliter, there were no serious adverse
events reported other than the common reports of myalgia, bone
pain, and headache associated with administration of cytokine.
Pain levels ranged from mild to severe. Pain was managed in most
cases by either over the counter analgesics and some required a
mild narcotic.
Our apheresis SOP directs nursing staff to contact the physician
when the pre-leukapheresis WBC is greater than 60,000/mcl. The
physician reviews the cytokine dose and the numbers of cells
collected and provides the apheresis nurse with orders for with-
holding a dose of cytokine or for a 50% dose reduction. The
circulating CD-34 count does not consistently correlate to the
elevated WBC and can drop rapidly when cytokines are withheld
which may be problematic if the target number of cells for trans-
plantation has not been reached. Careful nursing and physician
assessment and monitoring for adverse events in this donor pop-
ulation include pain levels, breathing difﬁculties, chest discomfort
and any neurological changes. After careful evaluation of the data,
we feel collections of CD-34 cell from donors and patients with
WBC greater than 60,000 can be safely performed (Table1).
Table 1. WBC vs CD-34
Auto Auto Auto Allo Allo Allo Total
WBC N WBC
Mean
CD-34
Mean
N WBC
Mean
CD-34
Mean
N
60-69 40 64.6 81.6 60 63.8 110.0 100
70-79 30 74.3 89.5 16 74.5 95.2 46
80-89 13 84.1 56.9 5 85.7 84.1 18
90-99 6 94 95.5 5 94.1 105.1 11
100 4 110.5 318.3 3 102.7 68.9 7
total 93 74.3 91.8 89 70.0 104.3 182
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THE NURSING ROLE IN THE ORIENTATION AND EDUCATION FOR
OUTPATIENT PRE-HSCT PATIENTS, FAMILIES, AND CAREGIVERS AT
THE SEATTLE CANCER CARE ALLIANCE
Buzy-Hummel, A.M. Seattle Cancer Care Alliance, Seattle, WA.
When patients, families, and caregivers arrive at the Seattle
Cancer Care Alliance in preparation for a Hemopoietic Stem Cell
Transplant, they are often overwhelmed with information and
clinic appointments. The HSCT clinic nurses play a pivotal role in
orienting and educating patients and caregivers as they are evalu-
ated for transplant. To ensure consistent education, a comprehen-
sive process of clinic visits, written education materials, and classes
was developed to support patients and caregivers through the ﬁrst
several weeks in the Outpatient Clinic. The nursing process and
clinics are supported by written policies and procedures that out-
line nursing responsibilities. The proposed poster will communi-
cate the SCCA nursing role in the pre transplant orientation and
education of patients, family and caregivers.
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ESTABLISHMENT OF A LONG-TERM ALLOGENEIC BLOOD AND MAR-
ROW FOLLOW-UP PROGRAM FOR EARLY DETECTION OF COMPLICA-
TIONS AND MEASURING OUTCOMES
Neumann, J.L., Trevino, C.M., Hsu, Y., Popat, U., Champlin, R.E.,
Couriel, D. The University of Texas M. D. Anderson Cancer Center,
Houston, TX.
Almost 60% of the 613 patients transplanted at our center last
year received allogeneic blood or marrow transplantation. Alloge-
neic BMT complications are most prevalent in the ﬁrst 100 days,
but late infections and chronic graft versus host disease frequently
occur after patients leave our comprehensive cancer center at day
100. Establishing a thorough, comprehensive and central computer
accessible patient assessment will enable practitioners to phone
triage problems with community healthcare providers and identify
changes during follow-up visits for prevention, early detection of
complication, and prompt referrals. At our center the patient’s
initial BMT physician remains involved in the care throughout the
transplant process and follow-up. Referrals to our GVHD clinic
occur as deemed appropriate by the clinic physician. Capture of the
overall program incidence and severity of complications like
GVHD can be problematic. We have assigned one full-time Nurse
Practitioner (NP) to follow the allogeneic patients from day 80-
100 to the end of the ﬁrst year after transplantation. The LTFU
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